Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia
- 1 July 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (7) , 1041-1045
- https://doi.org/10.1016/0277-5379(87)90356-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.Journal of Clinical Oncology, 1985
- Treatment of patients with acute nonlymphocytic leukemia in relapse: A leukemia intergroup studyAmerican Journal of Hematology, 1985
- How much is too much high-dose cytosine arabinoside?Journal of Clinical Oncology, 1985
- Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosineCancer, 1984
- Therapeutic Activity of 4-Demethoxydauno-Rubicin (Idarubicin) in Adult Acute LeukemiaTumori Journal, 1983
- Antileukemic Activity of 4-Demethoxydaunorubicin in MiceTumori Journal, 1980